SLC2A3 (alias GLUT3) encodes a glucose transporter with a five-fold higher affinity for glucose than its ubiquitous family member GLUT1 (Simpson et al. 2008), making its expression an advantage in glucose-poor microenvironments with high glucose demands, such as in certain tumour environments. Here, SLC2A3 is linked to neoplasm.